Comparison of GreenLight 180-W XPS laser vaporization versus transurethral resection of the prostate: Outcomes of a single regional center
Submitted: April 22, 2020
Accepted: May 31, 2020
Published: October 1, 2020
Accepted: May 31, 2020
Abstract Views: 1035
PDF: 591
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Basri Cakiroglu, Orhun Sinanoglu, Akif Nuri Dogan, Safety of greenlight photoselective vaporisation of prostate in lower urinary tract symptoms due to benign prostatic hyperplasia in patients using anticoagulants due to cardiovascular comorbidities , Archivio Italiano di Urologia e Andrologia: Vol. 87 No. 2 (2015)
You may also start an advanced similarity search for this article.